Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 204524 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 245620 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 247214 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 268974 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 277811 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 320752 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 352534 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 362659 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 366077 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 369396 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 399640 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 414447 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 419692 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 501100 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 514488 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 574173 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 618545 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 633552 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 668226 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 770343 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 807998 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 827098 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 858309 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 1040706 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 1204269 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | LAUROYLCARNITINE (M+H)+ | 1736243 | Peak area normalized | male | Diabetic | Neuropathy |